HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health, Beauty And Wellness News: Nutrition 21 Scores In Brand Awareness

This article was originally published in The Rose Sheet

Executive Summary

GT's Living autumn kombucha; Mommez Choice and Eosera expand children's products; ThriveFit from level brands; Herbalife sponsors LA triathlon; Amino4U capsules, powder help patients recover from injuries, surgeries; Designer Protein's whey in Target; HumanN brand adds SuperBeets Immune; and Nutrition 21 ads west coast sales manager.

You may also be interested in...



OTC Ear Care Firm Eosera Gets Earful From US FDA On Pain And Itch Remedies, GMP Compliance

Eosera has removed its Ear Pain MD and Ear Itch MD products from e-commerce pages on its website following FDA's warning letter. The warning identifying the pain and itch products as unapproved new drugs also states that a January inspection of the firm’s facility found GMP violations. 

Health And Wellness Market News: X Out Acne Line In GNC, Eosera In Rite Aid

Proactiv marketer Guthy Renker introduces X Out acne line in GNC stores; Eosera reaches Rite Aid, plans extensions; ANSI meeting discusses supply chain safety, standards; and Dr. Reddy’s launches Mucinex D equivalent.

ThermoLife Tries To Flex Litigation Muscle Against Nitrate Marketers In False Advertising Complaints

ThermoLife International files two false advertising complaints alleging competitors also marketing nitrate-based workout products deceive consumers and disparage its business. The company is seeking damages after setbacks in patent infringement complaints.

Topics

UsernamePublicRestriction

Register

LL1134043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel